Using CD45, CK and DAPI (to capture immune cells, tumor and epithelial cells, and for segmentation, respectively) we selected for each patient defined micro-regions of interest that were subjected to spatial proteomic and transcriptional analyses. The gene discussed is PTPRC; the disease is neoplasm.